Claritev (Q132544684) belongs to the Zacks Medical Info Systems industry and outperformed the S&P 500 so far, based on information from August 6, 2025.
2 reports, 2 independent
Updated Aug 1
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Claritev (Q132544684) belongs to the Zacks Medical Info Systems industry and outperformed the S&P 500 so far, based on information from August 6, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Claims Intelligence service line drives revenue growth for Claritev.1 source
Claritev outperformed the market so far.1 source
Keep exploring
The entities involved
-
Claritev
American technology company supporting healthcare
Nothing else this week.
Coverage
Newest first; wire copies grouped- themarketsdaily.com
- ZacksClaritev Corporation (CTEV) Q2 Earnings and Revenues Surpass Estimates Claritev Corporation (CTEV) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of a loss